Correction to: Final results of the Choroid Plexus Tumor Study CPT-SIOP-2000
Johannes E. Wolff, Stefaan W. Van Gool, Tezer Kutluk, Blanca Diez, Rejin Kebudi, Beate Timmermann, Miklos Garami, Jaroslav Sterba, Gregory N. Fuller, Brigitte Bison, Uwe R. Kordes
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGlioma Diagnosis and Treatment · Cerebrospinal fluid and hydrocephalus
Correction to: Journal of Neuro-Oncology (2022) 156:599–613
10.1007/s11060-021-03942-0
In this article, we have identified a minor numerical error in the second subsection in the Methods and materials; see the bold text in the incorrect and correct sentences specified below. It affects the accuracy of the article, but does not invalidate the conclusion. The corresponding supplemental figures were all correct.
Incorrect:
“Six cycles of chemotherapy were repeated every 28 days and consisted of etoposide 100 mg/msq on days 1–5, with vincristine 1.5 mg/msq on day 1. The third drug was randomized to either carboplatin 350 mg/msq on days 1 and 2 (Supplemental Fig. 1a: CarbEV) or cyclophosphamide 1 g/msq on days 1 and 2 (Supplemental Fig. 1b: CycEV).”
Correct:
“Six cycles of chemotherapy were repeated every 28 days and consisted of etoposide 100 mg/msq on days 1–5, with vincristine 1.5 mg/msq on day 5. The third drug was randomized to either carboplatin 350 mg/msq on days 2 and 3 (Supplemental Fig. 1a: CarbEV) or cyclophosphamide 1 g/msq on days 2 and 3 (Supplemental Fig. 1b: CycEV).”
The original article has been corrected.